Long-term survivorship at a price: Late-term, therapy-associated toxicities in the adult Hodgkin lymphoma patient

Therapeutic Advances in Hematology

Volumn 2, Issue 2, 2011, Pages 111-119

  Straus, David J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Hodgkin lymphoma long term survivorship

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CONTRACEPTIVE AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GOSERELIN; ORAL CONTRACEPTIVE AGENT; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ACUTE LEUKEMIA; ADVANCED CANCER; AUTOLOGOUS STEM CELL TRANSPLANTATION; AZOOSPERMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CAROTID ARTERY OBSTRUCTION; CHILDHOOD CANCER; CRYOPRESERVATION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG DOSE ESCALATION; FEMALE FERTILITY; HEALTH STATUS; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LEUKEMIA; LONG TERM SURVIVAL; LUNG CANCER; LUNG DISEASE; MALE FERTILITY; MUSCLE ATROPHY; MYELODYSPLASTIC SYNDROME; OSTEOSARCOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RELAPSE; REVIEW; SECOND CANCER; SOFT TISSUE CANCER; THYROID CANCER;

EID: 84993810423     PISSN: 20406207     EISSN: 20406215     Source Type: Journal    
DOI: 10.1177/2040620711402414     Document Type: Review

References (65)

1. Abratt R.P. Morgan G.W. Silvestri G. Willcox P. (2004) Pulmonary complications of radiation therapy. Clin Chest Med 25: 167–177.
2. Adams M.J. Lipsitz S.R. Colan S.D. Tarbell N.J. Treves S.T. Diller L. et al. (2004) Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22: 3139–3148.
3. Aleman B.M. van Den Belt-Dusebout A.W. de Bruin M.L. Van't Veer M.B. Baaijens M.H. de Boer J.P. et al. (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109: 1878–1886.
4. Aleman B.M. van Den Belt-Dusebout A.W. Klokman W.J. Van't Veer M.B. Bartelink H. van Leeuwen F.E. (2003) Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21: 3431–3439.
5. Anselmo A.P. Cartoni C. Bellantuono P. Maurizi-Enrici R. Aboulkair N. Ermini M. (1990) Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP. Haematologica 75: 155–158.
6. Behringer K. Breuer K. Reineke T. May M. Nogova L. Klimm B. et al. (2005) Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 23: 7555–7564.
7. Behringer K. Wildt L. Mueller H. Mattle V. Ganitis P. van Den Hoonaard B. et al. (2010) No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a Phase II Trial from the German Hodgkin Study Group. Ann Oncol 21: 2052–2060.
8. Bhatia S. Robison L.L. Francisco L. Carter A. Liu Y. Grant M. et al. (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: Report from the Bone Marrow Transplant Survivor Study. Blood 105: 4215–4222.
9. Blumenfeld Z. Avivi I. Eckman A. Epelbaum R. Rowe J.M. Dann E.J. (2008) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89: 166–173.
10. Bowers D.C. McNeil D.E. Liu Y. Yasui Y. Stovall M. Gurney J.G. et al. (2005) Stroke as a late treatment effect of Hodgkin's Disease: A Report from the Childhood Cancer Survivor Study. J Clin Oncol 23: 6508–6515.
11. Breitbart W. Alici Y. (2010) Psychostimulants for cancer-related fatigue. J Natl Compr Canc Netw 8: 933–942.
12. Brusamolino E. Anselmo A.P. Klersy C. Santoro M. Orlandi E. Pagnucco G. et al. (1998) The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: A case-control study. Haematologica 83: 812–823.
13. Brusamolino E. Baio A. Orlandi E. Arcaini L. Passamonti F. Griva V. et al. (2006) Long-term events in adult patients with clinical stage Ia-IIa nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: A single-institution 15-year follow-up. Clin Cancer Res 12: 6487–6493.
14. Courneya K.S. Sellar C.M. Stevinson C. McNeely M.L. Peddle C.J. Friedenreich C.M. et al. (2009) Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 27: 4605–4612.
15. de Bruin M.L. Huisbrink J. Hauptmann M. Kuenen M.A. Ouwens G.M. Van't Veer M.B. et al. (2008) Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 111: 101–108.
16. de Bruin M.L. Sparidans J. Van't Veer M.B. Noordijk E.M. Louwman M.W. Zijlstra J.M. et al. (2009) Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes. J Clin Oncol 27: 4239–4246.
17. de Meestere I. Simon P. Emiliani S. Delbaere A. Englert Y. (2007) Fertility preservation: Successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist 12: 1437–1442.
18. Diller L. Medeiros Nancarrow C. Shaffer K. Matulonis U. Mauch P. Neuberg D. et al. (2002) Breast cancer screening in women previously treated for Hodgkin's disease: A prospective cohort study. J Clin Oncol 20: 2085–2091.
19. Dores, G.M., Anderson, W.F., Beane Freeman, L.E., Fraumeni Jr, J.F. and Curtis, R.E. (2010) Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy. Br J Cancer 103: 1081–1084.
20. Dores G.M. Metayer C. Curtis R.E. Lynch C.F. Clarke E.A. Glimelius B. et al. (2002) Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20: 3484–3494.
21. Engert A. Diehl V. Franklin J. Lohri A. Dorken B. Ludwig W.D. et al. (2009) Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 Years of follow-up of the GHSG HD 9 study. J Clin Oncol 27: 4548–4554.
22. Engert A. Plutschow A. Eich H.T. Lohri A. Dorken B. Borchmann P. et al. (2010) Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 363: 640–652.
23. Ferguson R.J. Ahles T.A. Saykin A.J. McDonald B.C. Furstenberg C.T. Cole B.F. et al. (2007) Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 16: 772–777.
24. Fobair P. Hoppe R.T. Bloom J. (1986) Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 4: 805–814.
25. Ford J.S. Schwartz J. McCallen L.N. Matasar M.J. Butos J.N. Reidel E.R. et al. (2008) Psychosocial functioning in survivors of Hodgkin lymphoma (Hl) treated during adulthood. J Clin Oncol 26(Suppl): abstract 9592–abstract 9602.
26. Geenen M.M. Cardous-Ubbink M.C. Kremer L.C. van Den Bos C. van der Pal H.J. Heinen R.C. et al. (2007) Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297: 2705–2715.
27. Geffen D.B. Blaustein A. Amir M. Cohen Y. (2003) Post-traumatic stress disorder and quality of life in long-term survivors of hodgkin's disease and non-Hodgkin's lymphoma in Israel. Leuk Lymphoma 44: 1925–1929.
28. Green D.M. Hyland A. Barcos M.P. Reynolds J.A. Lee R.J. Hall B.C. et al. (2000) Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 18: 1492–1499.
29. Herschbach P. Book K. Dinkel A. Berg P. Waadt S. Duran G. et al. (2010) Evaluation of two group therapies to reduce fear of progression in cancer patients. Supportive Care Cancer 18: 471–479.
30. Heutte N. Flechtner H.H. Mounier N. Mellink W.A. Meerwaldt J.H. Eghbali H. et al. (2009) Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H 8 randomised controlled trial. Lancet Oncol 10: 1160–1170.
31. Hjermstad M.J. Oldervoll L. Fosså S.D. Holte H. Jacobsen A.B. Loge J.H. (2006) Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer 42: 327–333.
32. Hodgson D.C. Gilbert E.S. Dores G.M. Schonfeld S.J. Lynch C.F. Storm H. et al. (2007) Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 25: 1489–1497.
33. Hull M.C. Morris C.G. Pepine C.J. Mendenhall N.P. (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290: 2831–2837.
34. Joly F. Henry-Amar M. Arveux P. Reman O. Tanguy A. Peny A.M. et al. (1996) Late psychosocial sequelae in Hodgkin's disease survivors: A French population-based case-control study. J Clin Oncol 14: 2444–2453.
35. Kadan-Lottick N.S. Dinu I. Wasilewski-Masker K. Kaste S. Meacham L.R. Mahajan A. et al. (2008) Osteonecrosis in adult survivors of childhood cancer: A Report from the Childhood Cancer Survivor Study. J Clin Oncol 26: 3038–3045.
36. Kangas M. Bovbjerg D.H. Montgomery G.H. (2008) Cancer-related fatigue: A systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 134: 700–741.
37. Kornblith A.B. Anderson J. Cella D.F. Tross S. Zuckerman E. Cherin E. et al. (1992) Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. Cancer 70: 2214–2224.
38. Küpeli S. Hazirolan T. Varan A. Akata D. Alehan D. Hayran M. et al. (2010) Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol 28: 1025–1030.
39. Majhail N.S. Ness K.K. Burns L.J. Sun C.L. Carter A. Francisco L. et al. (2007) Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Biol Blood Marrow Transplant 13: 1153–1159.
40. Matasar M.J. McCallen L.N. Reidel E.R. Ford J.S. Oeffinger K.S. Straus D. (2009) Late mortality and morbidity of patients with Hodgkin lymphoma treated in adulthood. J Clin Oncol 27(Suppl): abstract 8547.
41. May A.M. Korstjens I. van Weert E. van Den Borne B. Hoekstra-Weebers J.E.H.M. van der Schans C.P. et al. (2009) Long-term effects on cancer survivors' quality of life of physical training versus physical training combined with cognitive-behavioral therapy: Results from a randomized trial. Supportive Care Cancer 17: 653–663.
42. Meirow D. Baum M. Yaron R. Levron J. Hardan I. Schiff E. et al. (2007) Ovarian tissue cryopreservation in hematologic malignancy: Ten years' experience. Leuk Lymphoma 48: 1569–1576.
43. Metayer C. Lynch C.F. Clarke E.A. Glimelius B. Storm H. Pukkala E. et al. (2000) Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18: 2435–2443.
44. Mols F. Vingerhoets A.J.J.M. Coebergh J.W. Vreugdenhil G. Aaronson N.K. Lybeert M.L.M. et al. (2006) Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: A population-based study. Eur J Cancer 42: 2794–2801.
45. Montoto S. Canals C. Rohatiner A.Z. Taghipour G. Sureda A. Schmitz N. et al. (2007) Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: An EBMT Registry Study. Leukemia 21: 2324–2331.
46. Myrehaug S. Pintilie M. Yun L. Crump M. Tsang R.W. Meyer R.M. et al. (2010) A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease. Blood 116: 2237–2240.
47. O'Brien M.M. Donaldson S.S. Balise R.R. Whittemore A.S. Link M.P. (2010) Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncology 28: 1232–1239.
48. Oeffinger K.C. Mertens A.C. Sklar C.A. Kawashima T. Hudson M.M. Meadows A.T. et al. (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355: 1572–1582.
49. O'Flaherty C. Hales B.F. Chan P. Robaire B. (2010) Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity. Fertil Steril 94: 1374–1379.
50. Oktay K. Sonmezer M. Barad D. Gleicher N. (2009) Trying to reduce ovarian damage in patients with hodgkin lymphoma using gnrh agonists? Fertil Steril 91: 298–299.
51. Oldervoll L.M. Kaasa S. Knobel H. Loge J.H. (2003) Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors – results from a pilot study. Eur J Cancer 39: 57–63.
52. Portlock C.S. Boland P. Hays A.P. Antonescu C.R. Rosenblum M.K. (2003) Nemaline myopathy: A possible late complication of Hodgkin's disease therapy. Hum Pathol 34: 816–818.
53. Schierle C. Winograd J.M. (2004) Radiation-induced brachial plexopathy: Review. Complication without a cure. J Reconstr Microsurg 20: 149–152.
54. Schonfeld S.J. Gilbert E.S. Dores G.M. Lynch C.F. Hodgson D.C. Hall P. et al. (2006) Acute myeloid leukemia following Hodgkin lymphoma: A population-based study of 35,511 patients. J Natl Cancer Inst 98: 215–218.
55. Sieniawski M. Franklin J. Nogova L. Glossmann J.-P. Schober T. Nisters-Backes H. et al. (2007) Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. J Clin Oncol 25: 2000–2005.
56. Sieniawski M. Reineke T. Nogova L. Josting A. Pfistner B. Diehl V. et al. (2008) Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: A report of the German Hodgkin Study Group (GHSG). Blood 111: 71–76.
57. Sklar C. Whitton J. Mertens A. Stovall M. Green D. Marina N. et al. (2000) Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85: 3227–3232.
58. Swerdlow A.J. Barber J.A. Hudson G.V. Cunningham D. Gupta R.K. Hancock B.W. et al. (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18: 498–509.
59. Taylor A.J. Taylor R.E. (2009) Surveillance for breast cancer after childhood cancer. JAMA 301: 435–436.
60. Travis L.B. Gospodarowicz M. Curtis R.E. Clarke E.A. Andersson M. Glimelius B. et al. (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94: 182–192.
61. Travis L.B. Hill D.A. Dores G.M. Gospodarowicz M. van Leeuwen F.E. Holowaty E. et al. (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290: 465–475.
62. Travis L.B. Hill D. Dores G.M. Gospodarowicz M. van Leeuwen F.E. Holowaty E. et al. (2005) Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97: 1428–1437.
63. van der Kaaij M.A.E. Heutte N. van Echten-Arends J. Raemaekers J.M.M. Carde P. Noordijk E.M. et al. (2009) Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group Trials. Haematologica 94: 1691–1697.
64. van Leeuwen F.E. Klokman W.J. Stovall M. Dahler E.C. Van't Veer M.B. Noordijk E.M. et al. (2003) Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95: 971–980.
65. van Leeuwen F.E. Klokman W.J. Veer M.B. Hagenbeek A. Krol A.D. Vetter U.A. et al. (2000) Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18: 487–497.